Description
Robust and sensitive competitive immunoassay for the determination of Semaglutide (GLP1R agonist) in human samples. Calibrated against Ozempic. Can be validated for animal samples upon request.
Kit features:
– Uses highly specific monoclonal antibodies with low cross reactivity
– Recovery rates are between 85 – 115%
– Ready to use with a standard protocol with break-apart pre-coated wells
– Validated as per US FDA guidelines for Bioassays and well optimized
– Precision CV <10%
– Can be used for quantification of generics and biosimilars